clofibrate has been researched along with Enlarged Liver in 22 studies
angiokapsul: contains clofibrate & insoitolnicotinate
| Excerpt | Relevance | Reference |
|---|---|---|
| "However, no hepatomegaly was observed in these animals." | 1.27 | Factors which may be significant regarding regulation of the clofibrate-dependent induction of hepatic peroxisomal beta-oxidation and hepatomegaly. ( Eliassen, K; Osmundsen, H, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (72.73) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (9.09) | 29.6817 |
| 2010's | 4 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asaoka, Y | 1 |
| Togashi, Y | 1 |
| Mutsuga, M | 1 |
| Imura, N | 1 |
| Miyoshi, T | 1 |
| Miyamoto, Y | 1 |
| Makino, T | 1 |
| Kinoshita, J | 1 |
| Arakawa, S | 1 |
| Ito, K | 1 |
| Ando, Y | 1 |
| Yamoto, T | 1 |
| Teranishi, M | 1 |
| Sanbuissho, A | 1 |
| Nakayama, H | 1 |
| Nemoto, K | 3 |
| Tanaka, T | 1 |
| Ikeda, A | 1 |
| Ito, S | 1 |
| Mizukami, M | 1 |
| Hikida, T | 1 |
| Gamou, T | 3 |
| Habano, W | 2 |
| Ozawa, S | 3 |
| Inoue, K | 3 |
| Yoshida, M | 3 |
| Nishikawa, A | 3 |
| Degawa, M | 3 |
| Fujimoto, N | 1 |
| Youssef, JA | 1 |
| Bouziane, M | 1 |
| Badr, MZ | 1 |
| BEST, MM | 1 |
| DUNCAN, CH | 1 |
| AZARNOFF, DL | 1 |
| TUCKER, DR | 1 |
| BARR, GA | 1 |
| Kawashima, Y | 1 |
| Katoh, H | 1 |
| Kozuka, H | 1 |
| Eliassen, K | 1 |
| Osmundsen, H | 1 |
| Fort, FL | 1 |
| Stein, HH | 1 |
| Langenberg, K | 1 |
| Lewkowski, JP | 1 |
| Heyman, IA | 1 |
| Kesterson, JW | 1 |
| Berman, JS | 1 |
| Hiley, CR | 1 |
| Wilson, AC | 1 |
| Lazarow, PB | 1 |
| Shio, H | 1 |
| Leroy-Houyet, MA | 1 |
| Schladt, L | 1 |
| Hartmann, R | 1 |
| Timms, C | 1 |
| Strolin-Benedetti, M | 1 |
| Dostert, P | 1 |
| Wörner, W | 1 |
| Oesch, F | 1 |
| Lake, BG | 1 |
| Kozlen, SL | 1 |
| Evans, JG | 1 |
| Gray, TJ | 1 |
| Young, PJ | 1 |
| Gangolli, SD | 1 |
| Dalton, C | 1 |
| Hope, WC | 1 |
| Hope, HR | 1 |
| Sheppard, H | 1 |
| Baird, MB | 1 |
| Zimmerman, JA | 1 |
| Massie, HR | 1 |
| Samis, HV | 1 |
| Rozé, C | 1 |
| Debray, C | 1 |
| Vaille, C | 1 |
| Souchard, M | 1 |
| Hruban, Z | 1 |
| Gotoh, M | 1 |
| Slesers, A | 1 |
| Chou, SF | 1 |
| Kritchevsky, D | 1 |
| Tepper, SA | 1 |
| Elwood, JC | 1 |
| Richert, DA | 1 |
| Westerfeld, WW | 1 |
| Beckett, RB | 1 |
| Weiss, R | 1 |
| Stitzel, RE | 1 |
| Cenedella, RJ | 1 |
22 other studies available for clofibrate and Enlarged Liver
| Article | Year |
|---|---|
Histopathological image analysis of chemical-induced hepatocellular hypertrophy in mice.
Topics: Animals; Cell Nucleus; Clofibrate; Hepatocytes; Hepatomegaly; Hypertrophy; Image Processing, Compute | 2016 |
Comprehensive analysis of hepatic gene and protein expression profiles on phenobarbital- or clofibrate-induced hepatic hypertrophy in dogs.
Topics: Acyl-CoA Dehydrogenase; Animals; Carnitine O-Palmitoyltransferase; Clofibrate; Dogs; Electrophoresis | 2009 |
Super-induced gene expression of the N-methyl-D-aspartate receptor 2C subunit in chemical-induced hypertrophic liver in rats.
Topics: Animals; Clofibrate; Disease Models, Animal; Gene Expression; Hepatomegaly; Liver; Male; Oligonucleo | 2011 |
Altered expression of GADD45 genes during the development of chemical-mediated liver hypertrophy and liver tumor promotion in rats.
Topics: Animals; Cell Cycle Proteins; Clofibrate; Cytochrome P-450 Enzyme System; DNA Damage; Down-Regulatio | 2011 |
Estrogen and androgen receptor status in hepatocellular hypertrophy induced by phenobarbital, clofibrate, and piperonyl butoxide in F344 rats.
Topics: Animals; Carcinogens; CD36 Antigens; Clofibrate; Estrogen Receptor alpha; Female; Hepatomegaly; Leuk | 2012 |
Age-dependent effects of nongenotoxic hepatocarcinogens on liver apoptosis in vivo.
Topics: Aging; Animals; Apoptosis; Carcinogens; Cell Count; Cholesterol; Clofibrate; Hepatocytes; Hepatomega | 2003 |
HYPOLIPEMIA AND HEPATOMEGALY FROM ETHYL CHLOROPHENOXYISOBUTYRATE (CPIB) IN THE RAT.
Topics: Adrenalectomy; Androsterone; Anticholesteremic Agents; Butyrates; Castration; Cholesterol; Clofibrat | 1964 |
STUDIES WITH ETHYL CHLOROPHENOXYISOBUTYRATE (CLOFIBRATE).
Topics: Anticholesteremic Agents; Butyrates; Carbon Dioxide; Cholesterol; Clofibrate; Glycerides; Hepatomega | 1965 |
Differential effects of altered hormonal state on the induction of acyl-CoA hydrolases and peroxisomal beta-oxidation by clofibric acid.
Topics: Adrenalectomy; Animals; Clofibrate; Clofibric Acid; Dexamethasone; Diabetes Mellitus, Experimental; | 1983 |
Factors which may be significant regarding regulation of the clofibrate-dependent induction of hepatic peroxisomal beta-oxidation and hepatomegaly.
Topics: Adenosylmethionine Decarboxylase; Adrenalectomy; Animals; Clofibrate; Eflornithine; Hepatomegaly; Hy | 1984 |
Cetaben versus clofibrate: comparison of toxicity and peroxisome proliferation in rats.
Topics: 4-Aminobenzoic Acid; Aminobenzoates; Animals; Body Weight; Catalase; Clofibrate; Female; Hepatomegal | 1983 |
Comparison of the effects of the hypolipidaemic agents ICI53072 and clofibrate with those of phenobarbitone on liver size, blood flow and DNA content in the rat.
Topics: Animals; Bile; Cardiac Output; Clofibrate; DNA; Hepatomegaly; Hypolipidemic Agents; Liver; Liver Cir | 1983 |
Specificity in the action of hypolipidemic drugs: increase of peroxisomal beta-oxidation largely dissociated from hepatomegaly and peroxisome proliferation in the rat.
Topics: Animals; Bezafibrate; Cell Division; Cell Fractionation; Clofibrate; Clofibric Acid; Female; Hepatom | 1982 |
Concomitant induction of cytosolic but not microsomal epoxide hydrolase with peroxisomal beta-oxidation by various hypolipidemic compounds.
Topics: Animals; Aspirin; Clofibrate; Cytosol; Dose-Response Relationship, Drug; Enzyme Induction; Epoxide H | 1987 |
Effect of prolonged administration of clofibric acid and di-(2-ethylhexyl)phthalate on hepatic enzyme activities and lipid peroxidation in the rat.
Topics: Animals; Clofibrate; Clofibric Acid; Diethylhexyl Phthalate; Hepatomegaly; Lipid Peroxides; Liver; M | 1987 |
Relationship of serum triglyceride lowering to changes in hepatic composition induced by different classes of drugs.
Topics: Animals; Cholesterol; Clofibrate; Dactinomycin; DNA; Dose-Response Relationship, Drug; Glycolates; H | 1974 |
Response of liver and kidney catalase to alpha-p-chlorophenoxyisobutyrate (clofibrate) in C57B1/6J male mice of different ages.
Topics: Aging; Animals; Catalase; Clofibrate; Hepatomegaly; Kidney; Liver; Male; Mice; Mice, Inbred C57BL; O | 1974 |
[Induced hypercholeresis and excretion of bile salts after treatment with clofibrate].
Topics: Animals; Bicarbonates; Bile; Bile Acids and Salts; Bilirubin; Chlorine; Clofibrate; Hepatomegaly; Li | 1972 |
Structure of hepatic microbodies in rats treated with acetylsalicylic acid, clofibrate, and dimethrin.
Topics: Animals; Aspirin; Benzyl Compounds; Body Weight; Carboxylic Acids; Cholesterol; Chrysanthemum cinera | 1974 |
Effect of 2-acetoamidoethyl (p-chlorophenyl) (m-trifluoromethylphenoxy) acetate (halofenate) on cholesterol oxidation by rat liver mitochondria.
Topics: Acetamides; Animals; Anticholesteremic Agents; Autoradiography; Carbon Isotopes; Cholesterol; Clofib | 1972 |
A comparison of hypolipidemic drugs in the prevention of an orotic acid fatty liver.
Topics: Animals; Clofibrate; Diet; Electrophoresis; Ethylamines; Fatty Liver; Glucosephosphate Dehydrogenase | 1972 |
Studies on the hepatomegaly caused by the hypolipidemic drugs nafenopin and clofibrate.
Topics: Aniline Compounds; Animals; Clofibrate; DNA; Drug Interactions; Endoplasmic Reticulum; Hepatomegaly; | 1972 |